Adverse events
| Cilostazol (n=25) | Placebo (n=24) | p Value* | |
|---|---|---|---|
| Headache | 10 (40.0) | 5 (20.8) | 0.217 |
| Dizziness | 2 (8.0) | 2 (8.3) | 1.000 |
| Paresthesia | 1 (4.0) | 0 (0.0) | 1.000 |
| Palpitation | 2 (8.0) | 2 (8.3) | 1.000 |
| Bradycardia | 0 (0.0) | 1 (4.2) | 0.490 |
| Peripheral oedema | 1 (4.0) | 0 (0.0) | 1.000 |
| Chest discomfort | 1 (4.0) | 1 (4.2) | 1.000 |
| Gastrointestinal symptoms | 2 (8.0) | 1 (4.2) | 1.000 |
Adverse events are displayed as the number of subjects (percentage of subjects).
*p Value for difference between treatment (Fisher's exact test).